| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |